BridgeMD
New treatment option for Lung Transplant Rejection
Official title Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
ClinicalTrials.gov ID: NCT04837339
What this study is testing
- What it's testing
- Transplant results vary considerably from one organ to another. Lung transplantation has poorer long-term outcomes than other solid organ transplants, with a current median post-transplant survival of 6.0 years.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 and older
You may be able to join if
- Men or women over 15 years of age
- Suffering from a lung condition requiring a transplant planned at Foch Hospital or being followed up at Foch Hospital following a lung transplant
- Have signed the informed consent form and for patients aged 15 to 18 years that the person(s) exercising parental authority has/have signed the...
- Be affiliated with a Health Insurance plan.
You likely can't join if
- Pregnant, parturient and/or lactating woman
- Hemoglobin level less than or equal to 8g/dl
- Persons of full age who are subject to a legal protection measure or who are unable to express their consent
- Persons under the protection of justice
- Not being able to follow the study requirements for geographical, social or psychological reasons
- Patient refusal.
The study team makes the final eligibility decision.
Where it's taking place
- Suresnes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suresnes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.